title: [Tl-201 myocardial images in a patient with dialated cardiomyopathy, who finally received heart transplantation].
abstract: The patient responded to treatment at the first onset of heart failure but gradually became irresponsive to treatment, experiencing fatigue and malaise as the chief complaints and suffering from gradually progressive decrease in exercise capacity and body weight. Dose of DOA gradually increased to maintain well clinical state of the patient. Unusual for heart failure, he had bradycardia as the basal rhythm without showing a tendency for tachycardia. Cardiac catheterization revealed pulmonary hypertension and low cardiac output, however, left ventricular ejection fraction was 37%. There were no notable changes in ultrasonic cardiogram or CTR through the clinical course. Tl-201 myocardial images and pulmonary perfusion images showed gradual worsening corresponding to progressive worsening of clinical state. From these findings, the patient was determined as a candidate for heart transplantation.
authors.affiliation: Cardiovascular Institute, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
authors.forename: T
authors.initials: T
authors.lastname: Aizawa
authors.forename: K
authors.initials: K
authors.lastname: Katou
authors.forename: K
authors.initials: K
authors.lastname: Ogasawara
authors.forename: H
authors.initials: H
authors.lastname: Kirigaya
authors.forename: K
authors.initials: K
authors.lastname: Okamoto
mesh_terms: D019797:3-Iodobenzylguanidine; D000328:Adult; D000911:Antibodies, Monoclonal; D002311:Cardiomyopathy, Dilated / Q000000981:diagnostic imaging* / Q000601:surgery; D016027:Heart Transplantation; D006801:Humans; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008297:Male; D009942:Organometallic Compounds; D011877:Radionuclide Imaging; D013794:Thallium Radioisotopes
chemical_list: D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D009942:Organometallic Compounds; D013794:Thallium Radioisotopes; D019797:3-Iodobenzylguanidine; C058899:imciromab pentetate